The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propana
about
Recent development of ATP-competitive small molecule phosphatidylinostitol-3-kinase inhibitors as anticancer agentsAnalysis of phosphoinositide 3-kinase inhibitors by bottom-up electron-transfer dissociation hydrogen/deuterium exchange mass spectrometry.Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine TumorsConformational disruption of PI3Kδ regulation by immunodeficiency mutations in PIK3CD and PIK3R1.Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1).The role of PI3Kα isoform in cardioprotection.New Insights into PI3K Inhibitor Design using X-ray Structures of PI3Kα Complexed with a Potent Lead Compound.Tandem Aryne-Capture/Sigmatropic Rearrangement as a Metal-Free Entry to Functionalized N-Aryl Pyrrolidines.Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.Gelidiella acerosa inhibits lung cancer proliferation.Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
P2860
Q28067417-5DD175BA-CAE3-4713-8AD2-75B13554CF31Q38288444-80FF8025-E1F5-4C96-B6F2-269B6C409872Q39735943-C192F013-5C18-4F01-A401-977507EB700BQ42318124-ECDA829E-3D74-47AB-B489-62C253901932Q42348468-EB074D1F-DDFF-4718-9A9D-D41F165687C3Q42683501-4BCCC0DE-49CF-4157-BF9F-E867CE1F9AD5Q44167862-D83DDB5A-45D9-4131-AC9A-766E0DADDBA8Q48205804-B5924D13-0895-4127-BAF0-70B11734C621Q54117873-CF0B4DEE-9B83-4552-81FB-C2B365B3C3E0Q54120349-FB0D564D-4C90-45C0-A15B-B6CADF3B5874Q59128909-9FBD1C96-9F39-40BD-845D-F938C417E3E4
P2860
The Rational Design of Selective Benzoxazepin Inhibitors of the α-Isoform of Phosphoinositide 3-Kinase Culminating in the Identification of (S)-2-((2-(1-Isopropyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)oxy)propana
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The Rational Design of Selecti ...... [1,4]oxazepin-9-yl)oxy)propana
@nl
type
label
The Rational Design of Selecti ...... [1,4]oxazepin-9-yl)oxy)propana
@nl
prefLabel
The Rational Design of Selecti ...... [1,4]oxazepin-9-yl)oxy)propana
@nl
P2093
P1476
The Rational Design of Selecti ...... -yl)oxy)propanamide (GDC-0326)
@en
P2093
Alan G Olivero
Aleksander Kolesnikov
BinQing Wei
Chudi Ndubaku
Cristina Lewis
Deepak Sampath
Emanuela Gancia
Graham Jones
Jeffrey Wallin
Jim Nonomiya
P304
P356
10.1021/ACS.JMEDCHEM.5B01483
P407
P577
2016-02-11T00:00:00Z